Jansson Sven-Arne, Lindberg Anne, Ericsson Asa, Borg Sixten, Rönmark Eva, Andersson Fredrik, Lundbäck Bo
The OLIN Studies, Department of Medicine, Sunderby Central Hospital of Norrbotten, SE-971 80 Luleå, Sweden.
COPD. 2005 Dec;2(4):427-34. doi: 10.1080/15412550500346501.
Previous studies have presented divergent estimates of the cost of illness of COPD due to differences in methodology. The objective of this study was to examine differences between register-based estimates versus population-based estimates on the burden of COPD. This study therefore examined differences in costs of COPD among physician-diagnosed and un-diagnosed subjects. During a one-year period, four telephone interviews were made with 212 randomly selected subjects with COPD derived from the Obstructive Lung Disease in Northern Sweden (OLIN) studies. Health care resource utilization and productivity losses were measured, and the costs were also transformed with the estimated COPD prevalence in Sweden. Average annual costs were SEK 18,252 (USD 2,207, EUR 2,072), and SEK 9,327 (USD 1,128, EUR 1,059) for subjects with and without a physician-diagnosis, respectively. Although lower per individual, the costs of undiagnosed subjects accounted for approximately 40% of the total costs in Sweden, since the majority of subjects with COPD in Sweden lack a physician-diagnosed disease. In conclusion, we found that the costs due to COPD differed considerably between those with and without physician-diagnosed disease. This study indicates that register-based studies result in underestimated costs of COPD.
由于方法学上的差异,先前的研究对慢性阻塞性肺疾病(COPD)的疾病成本给出了不同的估计。本研究的目的是检验基于登记的估计与基于人群的估计在COPD负担方面的差异。因此,本研究考察了经医生诊断和未经诊断的受试者在COPD成本上的差异。在一年时间里,对从瑞典北部阻塞性肺病(OLIN)研究中随机选取的212名COPD患者进行了四次电话访谈。测量了医疗保健资源利用情况和生产力损失,并且还根据瑞典估计的COPD患病率对成本进行了换算。有医生诊断的受试者和无医生诊断的受试者的年均成本分别为18,252瑞典克朗(2,207美元,2,072欧元)和9,327瑞典克朗(1,128美元,1,059欧元)。尽管无诊断受试者的人均成本较低,但由于瑞典大多数COPD患者没有医生诊断的疾病,他们的成本占瑞典总成本的约40%。总之,我们发现有医生诊断疾病和无医生诊断疾病的患者在COPD成本上存在很大差异。这项研究表明,基于登记的研究导致对COPD成本的低估。